Washington (AFP) – An experimental drug from Swiss pharma giant Novartis reduced deaths from chronic heart failure by 20 percent compared with an existing treatment, according to the results of a vast new study.
The new drug, called LCZ696, has been labelled a potential…
Tests promise ‘blockbuster’ new heart failure drug
Sunday, August 31, 2014
Tests promise ‘blockbuster’ new heart failure drug
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment